Company intelligence / Profile preview

Single Use Support

Ownership: Private
Employees: ~101
Development stage: Commercial

Overview

Single Use Support offers advanced, modular solutions for fluid management in the biopharmaceutical industry. Their systems enable safe, efficient filling, freezing/thawing, storage, and shipping of high-value drug substances—including those used in cell/gene therapies and mRNA vaccines—helping reduce product loss to near zero while supporting GMP compliance and patient safety. The company has demonstrated rapid growth with significant expansion into the US market.

Modalities: AntibodyMonoclonal antibodymRNA-based drugsCell therapyGene therapyVaccineBiologic
Industry: Chemicals & Materials

Partnerships

Collaborations with pharmaceutical manufacturers and CDMOs globallyPartnership with National Center for Therapeutics Manufacturing at Texas A&M University on mRNA vaccine production program

Beyond the preview

Go deeper on Single Use Support.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single Use Support.

Explore the full profile